Apple Inc (NASDAQ:AAPL, ETR:APC) has removed the blood oxygen monitoring feature on its latest range of smartwatches to avoid a US import ban. US Customs and Border Protection decided that the Apple Watch Series 9 and Ultra 2 were no longer subject to an import ban after the tech company removed the pulse oximeter feature from the products. The US International Trade Commission (ITC) placed the ban on the Apple products towards the end of 2023 after Masimo, the medical technology company, claimed the watche ...

About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...

About this content About Stephen Gunnion Stephen Gunnion is a senior financial journalist and broadcaster at Proactive Investors. He has more than 25 years of experience in television, radio and print media, anchoring on a number of television channels including South Africa's Business Day TV, CNBC Africa and the South African Broadcasting Corporation, where he was the economics editor. He has also worked for Daily Maverick, Bloomberg, the Business Day newspaper and Investors' Chronicle. Read more About ...

In the seven years since its launch, Nintendo has not once cut the price of its rabidly popular Switch gaming console. Nor should it: the Switch has sold over 132 million units, making it the Japanese gaming giant’s second-best-selling device behind the Nintendo DS. Killer apps like The Legend of Zelda: Tears of the Kingdom, Super Mario Bros Wonder and Metroid Prime Remastered ensured Switch sales kept ticking along well into 2023. If not cutting prices is a surefire sign of a product’s enduring popularity, ...

Stifel has identified Novo Nordisk (NYSE:NVO), Merck KGaA, and Sandoz as top picks in the European pharmaceutical sector for the first quarter of 2024, according to its recent research note. Novo Nordisk is highlighted for its exceptional growth outlook, with analysts anticipating over 20% growth in 2024, distinct from its big pharma peers. Key drivers for this growth include the potential approval of a weekly insulin product and new data for semaglutide (Ozempic/Wegovy) in heart failure-preserved ejection ...

Bitcoin (BTC) suffered further selling pressure after the long-awaited approval in the US of spot-bitcoin exchange-traded funds (ETFs) led to a ‘sell-the-news’ situation for the world’s largest cryptocurrency. Following a surprising high-single-digit dip on Friday, a day after the likes of BlackRock Inc (NYSE:BLK), Grayscale and Cathie Wood’s Ark Invest secured permission to list the bitcoin-tracking ETFs on the stock market, the BTC/USD pair traded flat on Saturday before running 2.6% lower on Sunday. Bitc ...

About this content About Andrew Kessel Andrew is a financial journalist with experience covering public companies in a wide breadth of industries, including tech, medicine, cryptocurrency, mining and retail. In addition to Proactive, he has been published in a Financial Times-owned newsletter covering broker-dealer firms and in the Columbia Misourian newspaper as the lead reporter focused on higher education. He got his start with an internship at Rolling Stone magazine.  Read more About the publisher Pr ...

Nvidia Corporation (NASDAQ:NVDA) shares rallied by more than 13% this week to new highs on Nasdaq, prompting sceptics to wonder if the stock could be overvalued, overbought or a stock bubble.   Last year, its stock tripled in value as excitement around artificial intelligence (AI) began to build, and since then has continued to climb.  The stock was already a standout performer in the S&P 500 last year and broke new records this month.   This latest rally in the tech company’s stock follows the unveiling of ...

About this content About Stephen Gunnion Stephen Gunnion is a senior financial journalist and broadcaster at Proactive Investors. He has more than 25 years of experience in television, radio and print media, anchoring on a number of television channels including South Africa's Business Day TV, CNBC Africa and the South African Broadcasting Corporation, where he was the economics editor. He has also worked for Daily Maverick, Bloomberg, the Business Day newspaper and Investors' Chronicle. Read more About ...

BlackRock has splashed out US$12.5bn to beef up its alternatives and infrastructure portfolio through the acquisition of Global Infrastructure Partners (GIP). Already the world’s largest fund manager, GIP brings with the US$100bn portfolio containing airports, such as London’s Gatwick, toll roads and bridges, green energy projects and data centres. Adebayo Ogunlesi, GIP’s founder, will join the Blackrock board on completion of the shares and cash deal. “The unprecedented need for new infrastructure – for di ...